New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury

Drug-induced liver injury (DILI) is one of the leading causes of acute liver injury. Many factors may contribute to the susceptibility of patients to this condition, making DILI a global medical problem that has an impact on public health and the pharmaceutical industry. The use of mesenchymal stem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezquer, Fernando, Huang, Ya-Lin, Ezquer, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910533/
https://www.ncbi.nlm.nih.gov/pubmed/35269830
http://dx.doi.org/10.3390/ijms23052669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910533/
https://www.ncbi.nlm.nih.gov/pubmed/35269830
http://dx.doi.org/10.3390/ijms23052669

Ejemplares similares